Howe & Rusling’s Express Scripts Holding Company ESRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-120
Closed -$8K 994
2018
Q1
$8K Buy
+120
New +$9.15K ﹤0.01% 539
2017
Q1
Sell
-460
Closed -$32K 1086
2016
Q4
$32K Hold
460
0.01% 314
2016
Q3
$32K Sell
460
-350
-43% -$26.2K 0.01% 308
2016
Q2
$61K Sell
810
-79,111
-99% -$5.82M 0.01% 229
2016
Q1
$5.49M Sell
79,921
-3,310
-4% -$238K 1.24% 29
2015
Q4
$7.28M Sell
83,231
-1,594
-2% -$137K 1.67% 11
2015
Q3
$6.87M Sell
84,825
-1,515
-2% -$132K 1.71% 12
2015
Q2
$7.68M Sell
86,340
-3,630
-4% -$317K 1.67% 11
2015
Q1
$7.81M Buy
89,970
+1,385
+2% +$116K 1.75% 12
2014
Q4
$7.5M Sell
88,585
-90
-0.1% -$7.03K 1.8% 8
2014
Q3
$6.26M Sell
88,675
-1,380
-2% -$98.3K 1.46% 20
2014
Q2
$6.24M Sell
90,055
-725
-0.8% -$51K 1.4% 24
2014
Q1
$6.82M Buy
90,780
+18,915
+26% +$1.42M 1.67% 17
2013
Q4
$5.05M Buy
71,865
+29,680
+70% +$1.94M 1.27% 30
2013
Q3
$2.61M Sell
42,185
-29,585
-41% -$1.91M 0.95% 37
2013
Q2
$4.43M Buy
+71,770
New +$4.32M 1.23% 29

Other funds holding ESRX

Howe & Rusling's ESRX Position: Q2 2018 in Review

Howe & Rusling sold out of Express Scripts Holding Company (ESRX) in Q2 2018, closing a stake of 120 shares — an estimated $8K sold.

Howe & Rusling first reported a position in ESRX in Q2 2013 and held it in 16 quarters. The position peaked at $7.81M in Q1 2015. 1,109 funds tracked by Wall St. Rank hold ESRX as of Q2 2018.

  • Howe & Rusling reported no remaining Express Scripts Holding Company position as of Q2 2018 after selling out during the quarter.
  • Howe & Rusling sold 120 Express Scripts Holding Company shares in Q2 2018, an estimated $8K.
  • Howe & Rusling first reported a position in Express Scripts Holding Company in Q2 2013 and held it in 16 quarters.
  • Howe & Rusling's Express Scripts Holding Company position peaked at $7.81M in Q1 2015.
  • 1,109 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q2 2018.

Based on Howe & Rusling's 13F filing for Q2 2018, filed 31 Jul 2018.